Needham & Company raised its price objective on Blue Bird Corporation, with MarketBeat aggregating the consensus rating and target price.
1 report, 1 independent
Updated Jul 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Needham & Company raised its price objective on Blue Bird Corporation, with MarketBeat aggregating the consensus rating and target price.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Blue Bird Corporation
American bus manufacturer based in Georgia
Nothing else this week.
-
Needham & Company
American independent investment bank and asset management firm
Related events
- Needham & Company cut its target price and set a buy rating for Applied Optoelectronics, while Raymond James Financial reiterated an outperform rating. MarketBeat provided consensus data.
- Needham & Company downgraded Heron Therapeutics stock rating, while MarketBeat provided average stock rating data.
- Citigroup reissued a market outperform rating and Needham lifted its target price for Alkami Technology Inc.
- Needham & Company cut its price target and set a buy rating for Endava, while CLSA also set a $5.00 price objective.